Esophageal Cancer

Showing NaN - NaN of 72

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Endometrial Cancer, Esophageal Cancer, Esophagogastric Junction (EGJ) Trial in Worldwide (Autologous genetically modified

Recruiting
  • Endometrial Cancer
  • +8 more
  • Autologous genetically modified ADP-A2M4CD8 cells alone or in combination with nivolumab every four weeks or pembrolizumab every 6 weeks
  • Orlando, Florida
  • +21 more
Feb 2, 2023

Retrospective Review of Esophageal Cancer at MSKCC

Recruiting
  • Esophageal Cancer
  • Esophagus Cancer
  • Esophagectomy
  • New York, New York
    Memorial Sloan Kettering Cancer Center (All Protocol Activities)
Jan 23, 2023

Fragments for Early Interception - Lung Cancer Training Study

Recruiting
  • Lung Cancer
  • +8 more
  • Blood Sample Collection
  • New York, New York
  • +1 more
Nov 28, 2022

Prostate Cancer, Bladder Cancer, NSCLC Trial in New York, Houston (NY-ESO-1 Plasmid DNA Cancer Vaccine)

Completed
  • Prostate Cancer
  • +4 more
  • NY-ESO-1 Plasmid DNA Cancer Vaccine
  • New York, New York
  • +1 more
Oct 3, 2022

Melanoma, NSCLC, Breast Cancer Trial in United States (CDX-1140, CDX-301, Pembrolizumab)

Completed
  • Melanoma
  • +25 more
  • Scottsdale, Arizona
  • +10 more
Sep 27, 2022

Esophageal Cancer, Esophagogastric Junction Cancer Trial in Worldwide (Autologous genetically modified ADP-A2M4CD8 cells)

Recruiting
  • Esophageal Cancer
  • Esophagogastric Junction Cancer
  • Autologous genetically modified ADP-A2M4CD8 cells
  • Duarte, California
  • +33 more
Aug 23, 2022

Ovarian Cancer, Ovarian Tumors, Ovarian Carcinoma Trial in United States (ELU001)

Recruiting
  • Ovarian Cancer
  • +68 more
  • Phoenix, Arizona
  • +8 more
Aug 18, 2022

Intestinal Microbiome, Oral Microbiome, and Whole Blood

Recruiting
  • Gastrointestinal Cancer
  • +6 more
    • New York, New York
      Icahn School of Medicine at Mount Sinai
    Aug 5, 2022

    Solid Tumor, Adult, Head Neck Cancer, Non Small Cell Lung Cancer Trial in Worldwide (CX-2029)

    Active, not recruiting
    • Solid Tumor, Adult
    • +4 more
    • Birmingham, Alabama
    • +24 more
    Aug 5, 2022

    Esophageal Adenocarcinoma, Esophageal Cancer, HER-2 Protein Overexpression Trial in New York, Providence (Nivolumab, Trastuzumab

    Not yet recruiting
    • Esophageal Adenocarcinoma
    • +3 more
    • New York, New York
    • +1 more
    Jul 28, 2022

    Esophagogastric Tumors, Gastric Cancer, Gastric Tumor Trial in United States (Trastuzumab, Pembrolizumab)

    Recruiting
    • Esophagogastric Tumors
    • +9 more
    • Basking Ridge, New Jersey
    • +6 more
    Jul 8, 2022

    Advanced Solid Tumor, NSCLC, Melanoma Trial in United States (AB308, Zimberelimab)

    Recruiting
    • Advanced Solid Tumor
    • +9 more
    • Phoenix, Arizona
    • +20 more
    May 2, 2022

    Esophageal Cancer, Gastric Cancer Trial in United States (Afatinib and Paclitaxel)

    Active, not recruiting
    • Esophageal Cancer
    • Gastric Cancer
    • Afatinib and Paclitaxel
    • Los Angeles, California
    • +8 more
    Mar 18, 2022

    Kidney Cancer, Head Neck Cancer, Breast Cancer Trial in New York (177Lu-J591)

    Completed
    • Kidney Cancer
    • +8 more
    • New York, New York
      Weill Cornell Medical College
    Feb 1, 2022

    Tissue & Blood From Patients w/ Benign & Malignant Tumors of

    Active, not recruiting
    • Esophageal Cancer
    • +6 more
      • New York, New York
        Memorial Sloan Kettering Cancer Center
      Nov 12, 2021

      Adenocarcinoma of the Gastroesophageal Junction, Esophageal Cancer Trial in United States (drug, procedure, radiation)

      Active, not recruiting
      • Adenocarcinoma of the Gastroesophageal Junction
      • Esophageal Cancer
      • Mountain View, California
      • +67 more
      Oct 5, 2021

      Esophageal Cancer Trial in New York (other, device, procedure)

      Recruiting
      • Esophageal Cancer
      • Injection of indocyanine green (ICG)dye
      • +2 more
      • New York, New York
        Memorial Sloan Kettering Cancer Center (All Protocol Activities)
      Sep 29, 2021

      Clinical Management of Esophageal Adenocarcinoma (EAC)

      Active, not recruiting
      • Esophageal Cancer
      • Adenocarcinoma
      • serum and tissue mesothelin
      • New York, New York
        Memorial Sloan Kettering Cancer Center
      Oct 1, 2021

      Esophageal Cancer Trial in United States (cetuximab, ECF, IC)

      Completed
      • Esophageal Cancer
      • cetuximab
      • +3 more
      • Norwalk, Connecticut
      • +226 more
      Sep 2, 2021

      Esophageal Cancer, Gastric Cancer Trial in United States (pembrolizumab, trastuzumab, capecitabine)

      Active, not recruiting
      • Esophageal Cancer
      • Gastric Cancer
      • Basking Ridge, New Jersey
      • +7 more
      Sep 17, 2021

      Gastric Adenocarcinoma, Esophageal Cancer, Hepatocellular Carcinoma Trial in United States (Sacituzumab Govitecan-hziy (SG))

      Completed
      • Gastric Adenocarcinoma
      • +15 more
      • Sacituzumab Govitecan-hziy (SG)
      • Aurora, Colorado
      • +11 more
      Aug 10, 2021

      Following Minimally Invasive and Open Esophagectomy for

      Completed
      • Esophageal Cancer
      • Quality of Life instruments, FACT-E, Symptom Assessment Scale, Brief Pain Inventory and Daily Analgesic Log
      • New York, New York
        Memorial Sloan Kettering Cancer Center
      Aug 5, 2021

      Liver Cancer, Anxiety Disorder, Depression Trial in United States (Early palliative care)

      Completed
      • Liver Cancer
      • +9 more
      • Early palliative care
      • La Jolla, California
      • +22 more
      Jul 22, 2021